Privia Health Group (NASDAQ:PRVA) Coverage Initiated at KeyCorp

Analysts at KeyCorp began coverage on shares of Privia Health Group (NASDAQ:PRVA) in a report released on Friday, MarketBeat reports. The brokerage set an “overweight” rating and a $23.00 price target on the stock. KeyCorp’s price objective would indicate a potential upside of 31.05% from the company’s previous close.

Several other research analysts also recently commented on PRVA. Evercore ISI lowered their target price on Privia Health Group from $23.00 to $20.00 and set an “outperform” rating for the company in a research note on Tuesday, July 9th. Robert W. Baird increased their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a research note on Monday, August 26th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $28.00 target price on shares of Privia Health Group in a research note on Wednesday, August 14th. Two research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Privia Health Group has an average rating of “Buy” and a consensus target price of $24.73.

Privia Health Group Trading Up 2.5 %

NASDAQ PRVA opened at $17.55 on Friday. The firm’s 50 day simple moving average is $18.90 and its 200 day simple moving average is $18.34. The firm has a market capitalization of $2.09 billion, a price-to-earnings ratio of 117.00, a P/E/G ratio of 3.93 and a beta of 0.76. Privia Health Group has a 1 year low of $15.92 and a 1 year high of $24.35.

Privia Health Group (NASDAQ:PRVA) last released its earnings results on Thursday, August 8th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.02). Privia Health Group had a return on equity of 2.42% and a net margin of 0.88%. The business had revenue of $422.30 million for the quarter, compared to the consensus estimate of $411.50 million. During the same quarter in the previous year, the company earned $0.06 earnings per share. The firm’s revenue for the quarter was up 2.2% on a year-over-year basis. On average, equities research analysts forecast that Privia Health Group will post 0.16 earnings per share for the current year.

Insider Buying and Selling

In other Privia Health Group news, CEO Parth Mehrotra sold 135,142 shares of the company’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the sale, the chief executive officer now owns 247,771 shares of the company’s stock, valued at approximately $4,583,763.50. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 14.20% of the stock is owned by insiders.

Institutional Investors Weigh In On Privia Health Group

Institutional investors and hedge funds have recently made changes to their positions in the business. Canada Pension Plan Investment Board bought a new stake in Privia Health Group in the second quarter worth approximately $26,000. Nisa Investment Advisors LLC increased its stake in shares of Privia Health Group by 107.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock valued at $31,000 after acquiring an additional 930 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Privia Health Group by 98.7% during the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after acquiring an additional 845 shares during the period. Signaturefd LLC boosted its stake in Privia Health Group by 46.3% during the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after acquiring an additional 626 shares in the last quarter. Finally, Park Place Capital Corp grew its holdings in Privia Health Group by 115.4% in the first quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock worth $49,000 after purchasing an additional 1,335 shares during the period. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.